Registration
Description
About this event
Non-alcoholic steatohepatitis, or NASH, is the most severe form of non-alcoholic fatty liver disease (NAFLD).NASH is more than a liver disease, it is a complex cardio-metabolic disease with no approved treatment and represents a growing concern for the medical community. In Europe, an average of 23,7% adults is estimated to be affected by NAFLD*, which is closed to the global average (25% worldwide). This spectrum of non-alcoholic fatty liver disease is growing to become the most common chronic liver condition in Western populations, in relation to the obesity and type 2 diabetes epidemics, and the prevalence of NASH is also expected to increase.
In this conference, well-known experts in NASH will provide information on the disease progression and outcomes and discuss the challenges that the medical community faces. The speakers will also present current scientific, medical and advocacy projects aiming to address the public health crisis that represents NASH.
The conference is open to healthcare professionals, representants of public health authorities, patient groups, professional and academic organizations, patients and their family, industry.
* Younossi ZM. et al. Hepatology. 2016
In this conference, well-known experts in NASH will provide information on the disease progression and outcomes and discuss the challenges that the medical community faces. The speakers will also present current scientific, medical and advocacy projects aiming to address the public health crisis that represents NASH.
The conference is open to healthcare professionals, representants of public health authorities, patient groups, professional and academic organizations, patients and their family, industry.
* Younossi ZM. et al. Hepatology. 2016
Program and speakers
9:00 - 9:30 AM – Welcoming of attendees
9:30 - 9:45 AM – Introductory speech
9:45 - 10:15 AM – NASH, a looming public health crisis
- NASH: what is it and what are the outcomes?
- Epidemiology and socio-economic burden of NASH
10:15 - 10:45 AM – Challenges to raise public awareness
- The importance of raising awareness: a patient perspective
- Strategy to raise public and governmental awareness
10:45 - 11:00 AM – Coffee break
11:00 - 11:30 AM – Challenges for the medical community
- Challenges in NASH diagnosis
- Challenge of multidisciplinary approach: a practical example
11:30 - 11:45 AM – Q&A and Conclusion
11:45 - 13:00 PM – Lunch buffet and closing
Confirmed participation of:
- Prof. Sven Francque, MD PhD – Professor & Chair, Antwerp University Hospital (Belgium)
- Prof. Jörn Schattenberg, M.D. – Assistant Professor of Medicine at the University Medical Center Mainz (Germany)
- Prof. Massimo Colombo – Chairman of the EASL International Liver Foundation (EASL-ILF)
- Marko Korenjak – President of European Liver Patients Association (ELPA)
- Julio Burman – Vice-President of European Liver Patients Association (ELPA)
Join us or watch online
You cannot travel to Brussels? The conference will be live brodcast on The NASH Education Program's website. Register online by selecting Live Webcast Ticket - I will watch online to receive the link of the Live Webcast on June 12.
Leave a comment
Event
Conference "NASH, a looming public health crisis" in Brussels
12/06/2019 - 09:00 to 13:00
Hilton Brussels Grand Place
Carrefour de l'Europe 31000 Brussels
BELGIUM
Organizer contact
The NASH Education Program
Address : 885 Avenue Eugène Avinée
59120 Loos
FRANCE
Visual
